ArticleMedicine2026
Association between cardiometabolic index and mortality risk in patients with depression: A comprehensive analysis based on two national cohorts.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Depression is associated with increased cardiometabolic morbidity and mortality. However, the prognostic value of integrated biomarkers for mortality risk in this population is underexplored, particularly across different ethnicities. The cardiometabolic index (CMI), a composite measure of central obesity and dyslipidemia, has demonstrated predictive utility in general populations, but its role in depression is unknown. To investigate and validate the association between CMI and mortality risk in adults with depression using 2 large, nationally representative cohorts from the United States and China. This study utilized data from the National Health and Nutrition Examination Survey and the China Health and Retirement Longitudinal Study. CMI was calculated as the waist-to-height ratio multiplied by the triglyceride/high-density lipoprotein-cholesterol ratio. Cox proportional hazards models will be employed to examine the association between CMI and all-cause and cardiovascular mortality in participants with depression, after adjusting for potential confounders. This bi-national study evaluates CMI as a prognostic tool for mortality in the depression population. If its utility is confirmed, CMI could serve as a simple, cost-effective biomarker to identify high-risk individuals, facilitating targeted preventive strategies and improving clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.